182 related articles for article (PubMed ID: 12767001)
1. Hepatitis C virus infection among noninjecting drug users in New York City.
Koblin BA; Factor SH; Wu Y; Vlahov D
J Med Virol; 2003 Jul; 70(3):387-90. PubMed ID: 12767001
[TBL] [Abstract][Full Text] [Related]
2. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City.
Howe CJ; Fuller CM; Ompad DC; Galea S; Koblin B; Thomas D; Vlahov D
Drug Alcohol Depend; 2005 Sep; 79(3):389-95. PubMed ID: 16102381
[TBL] [Abstract][Full Text] [Related]
3. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users.
Neaigus A; Gyarmathy VA; Zhao M; Miller M; Friedman SR; Des Jarlais DC
J Infect Dis; 2007 Apr; 195(7):1052-61. PubMed ID: 17330797
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack.
Macías J; Palacios RB; Claro E; Vargas J; Vergara S; Mira JA; Merchante N; Corzo JE; Pineda JA
Liver Int; 2008 Jul; 28(6):781-6. PubMed ID: 18312289
[TBL] [Abstract][Full Text] [Related]
5. Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus.
Neaigus A; Miller M; Friedman SR; Des Jarlais DC
J Infect Dis; 2001 Aug; 184(3):359-63. PubMed ID: 11443564
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus-2 and HIV among noninjecting drug users in New York city.
Des Jarlais DC; Hagan H; Arasteh K; McKnight C; Perlman D; Friedman SR
Sex Transm Dis; 2007 Nov; 34(11):923-7. PubMed ID: 18049425
[TBL] [Abstract][Full Text] [Related]
7. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
8. Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population.
Hwang LY; Kramer JR; Troisi C; Bull L; Grimes CZ; Lyerla R; Alter MJ
Hepatology; 2006 Aug; 44(2):341-51. PubMed ID: 16871571
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C infection among drug users in northern Thailand.
Jittiwutikarn J; Thongsawat S; Suriyanon V; Maneekarn N; Celentano D; Razak MH; Srirak N; Vongchak T; Kawichai S; Thomas D; Sripaipan T; Netski D; Ananthakrishnan A; Nelson KE
Am J Trop Med Hyg; 2006 Jun; 74(6):1111-6. PubMed ID: 16760529
[TBL] [Abstract][Full Text] [Related]
10. Intranasal cocaine use does not appear to be an independent risk factor for HCV infection.
Galperim B; Cheinquer H; Stein A; Fonseca A; Lunge V; Ikuta N
Addiction; 2004 Aug; 99(8):973-7. PubMed ID: 15265094
[TBL] [Abstract][Full Text] [Related]
11. Brief counseling for reducing sexual risk and bacterial STIs among drug users--results from project RESPECT.
Semaan S; Neumann MS; Hutchins K; D'Anna LH; Kamb ML;
Drug Alcohol Depend; 2010 Jan; 106(1):7-15. PubMed ID: 19720471
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of hepatitis C virus and associated risk behaviours: a population-based study in San Juan, Puerto Rico.
Pérez CM; Suárez E; Torres EA; Román K; Colón V
Int J Epidemiol; 2005 Jun; 34(3):593-9. PubMed ID: 15802378
[TBL] [Abstract][Full Text] [Related]
13. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor JM
Drug Alcohol Depend; 2007 Jul; 89(2-3):244-50. PubMed ID: 17289299
[TBL] [Abstract][Full Text] [Related]
14. Individual and couple-level risk factors for hepatitis C infection among heterosexual drug users: a multilevel dyadic analysis.
McMahon JM; Pouget ER; Tortu S
J Infect Dis; 2007 Jun; 195(11):1572-81. PubMed ID: 17471426
[TBL] [Abstract][Full Text] [Related]
15. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users.
Roy KM; Goldberg DJ; Hutchinson S; Cameron SO; Wilson K; MacDonald L
J Med Virol; 2004 Sep; 74(1):62-6. PubMed ID: 15258969
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of hepatitis C infection in injecting drug users in Zadar County, Croatia.
Medić A; Dzelalija B; Sonicki Z; Zekanović D
Coll Antropol; 2008 Sep; 32(3):697-702. PubMed ID: 18982740
[TBL] [Abstract][Full Text] [Related]
18. FibroScan used in street-based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study.
Foucher J; Reiller B; Jullien V; Léal F; di Cesare ES; Merrouche W; Delile JM; de Lédinghen V
J Viral Hepat; 2009 Feb; 16(2):121-31. PubMed ID: 19175876
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.
Amon JJ; Garfein RS; Ahdieh-Grant L; Armstrong GL; Ouellet LJ; Latka MH; Vlahov D; Strathdee SA; Hudson SM; Kerndt P; Des Jarlais D; Williams IT
Clin Infect Dis; 2008 Jun; 46(12):1852-8. PubMed ID: 18462109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
